Evolution of bone marrow transplantation – the original immunotherapy
- 1 February 2001
- journal article
- review article
- Published by Elsevier BV in Trends in Immunology
- Vol. 22 (2), 88-92
- https://doi.org/10.1016/s1471-4906(00)01857-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemiaNature Medicine, 2000
- Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation?British Journal of Haematology, 2000
- b3a2 BCR-ABL fusion peptides as targets for cytotoxic T cells in chronic myeloid leukaemiaBritish Journal of Haematology, 2000
- Feasibility of Immunotherapy of Relapsed Leukemia With Ex Vivo–Generated Cytotoxic T Lymphocytes Specific for Hematopoietic System-Restricted Minor Histocompatibility AntigensBlood, 1999
- Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia.JCI Insight, 1998
- 9 Allografting for chronic myeloid leukaemiaBailliere's Clinical Haematology, 1997
- CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantationBlood, 1995
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic PhaseAnnals of Internal Medicine, 1988